Effective Identification of Bacterial Type III Secretion Signals Using Joint Element Features

Type III secretion system (T3SS) plays important roles in bacteria and host cell interactions by specifically translocating type III effectors into the cytoplasm of the host cells. The N-terminal amino acid sequences of the bacterial type III effectors determine their specific secretion via type III secretion conduits. It is still unclear as to how the N-terminal sequences guide this specificity. In this work, the amino acid composition, secondary structure, and solvent accessibility in the N-termini of type III and non-type III secreted proteins were compared and contrasted. A high-efficacy mathematical model based on these joint features was developed to distinguish the type III proteins from the non-type III ones. The results indicate that secondary structure and solvent accessibility may make important contribution to the specific recognition of type III secretion signals. Analysis also showed that the joint feature of the N-terminal 6th–10th amino acids are especially important for guiding specific type III secretion. Furthermore, a genome-wide screening was performed to predict Salmonella type III secreted proteins, and 8 new candidates were experimentally validated. Interestingly, type III secretion signals were also predicted in gram-positive bacteria and yeasts. Experimental validation showed that two candidates from yeast can indeed be secreted through Salmonella type III secretion conduit. This research provides the first line of direct evidence that secondary structure and solvent accessibility contain important features for guiding specific type III secretion. The new software based on these joint features ensures a high accuracy (general cross-validation sensitivity of ∼96% at a specificity of ∼98%) in silico identification of new type III secreted proteins, which may facilitate our understanding about the specificity of type III secretion and the evolution of type III secreted proteins.

[1]  Alan Collmer,et al.  Pseudomonas syringae Type III Secretion System Targeting Signals and Novel Effectors Studied with a Cya Translocation Reporter , 2004, Journal of bacteriology.

[2]  Gisbert Schneider,et al.  Prediction of Type III Secretion Signals in Genomes of Gram-Negative Bacteria , 2009, PloS one.

[3]  David S Guttman,et al.  Terminal Reassortment Drives the Quantum Evolution of Type III Effectors in Bacterial Pathogens , 2006, PLoS pathogens.

[4]  Dong Xu,et al.  Computational Identification of Protein Methylation Sites through Bi-Profile Bayes Feature Extraction , 2009, PloS one.

[5]  Tao Jiang,et al.  Computational prediction of type III secreted proteins from gram-negative bacteria , 2010, BMC Bioinformatics.

[6]  Masaki Iwabuchi,et al.  Genome-wide identification of a large repertoire of Ralstonia solanacearum type III effector proteins by a new functional screen. , 2010, Molecular plant-microbe interactions : MPMI.

[7]  Ruth Nussinov,et al.  A method for simultaneous alignment of multiple protein structures , 2004, Proteins.

[8]  G. Cornelis,et al.  Translocation of a hybrid YopE‐adenylate cyclase from Yersinia enterocolitica into HeLa cells , 1994, Molecular microbiology.

[9]  A. Collmer,et al.  The complete hrp gene cluster of Pseudomonas syringae pv. syringae 61 includes two blocks of genes required for harpinPss secretion that are arranged colinearly with Yersinia ysc homologs. , 1995, Molecular plant-microbe interactions : MPMI.

[10]  M. Karavolos,et al.  Type III Secretion of the Salmonella Effector Protein SopE Is Mediated via an N-Terminal Amino Acid Signal and Not an mRNA Sequence , 2005, Journal of bacteriology.

[11]  Alan Collmer,et al.  Genomewide identification of proteins secreted by the Hrp type III protein secretion system of Pseudomonas syringae pv. tomato DC3000 , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[12]  G. Geginat,et al.  Protection Against Murine Listeriosis by Oral Vaccination with Recombinant Salmonella Expressing Hybrid Yersinia Type III Proteins1 , 2001, The Journal of Immunology.

[13]  G. Frankel,et al.  Modelling of Infection by Enteropathogenic Escherichia coli Strains in Lineages 2 and 4 Ex Vivo and In Vivo by Using Citrobacter rodentium Expressing TccP , 2009, Infection and Immunity.

[14]  M. Shahid Mukhtar,et al.  Dynamic Evolution of Pathogenicity Revealed by Sequencing and Comparative Genomics of 19 Pseudomonas syringae Isolates , 2011, PLoS pathogens.

[15]  J. Galán,et al.  Identification of two targets of the type III protein secretion system encoded by the inv and spa loci of Salmonella typhimurium that have homology to the Shigella IpaD and IpaA proteins , 1995, Journal of bacteriology.

[16]  Tetsuya Hayashi,et al.  An extensive repertoire of type III secretion effectors in Escherichia coli O157 and the role of lambdoid phages in their dissemination , 2006, Proceedings of the National Academy of Sciences.

[17]  C. Hueck,et al.  Type III Protein Secretion Systems in Bacterial Pathogens of Animals and Plants , 1998, Microbiology and Molecular Biology Reviews.

[18]  Seema Mattoo,et al.  A genome‐wide screen identifies a Bordetella type III secretion effector and candidate effectors in other species , 2005, Molecular microbiology.

[19]  A. Collmer,et al.  Gene Ontology for type III effectors: capturing processes at the host-pathogen interface. , 2009, Trends in microbiology.

[20]  Fred Heffron,et al.  A multi-pronged search for a common structural motif in the secretion signal of Salmonella enterica serovar Typhimurium type III effector proteins. , 2010, Molecular bioSystems.

[21]  V. L. Miller,et al.  Identification of a Novel SalmonellaInvasion Locus Homologous to Shigella ipgDE , 1998, Journal of bacteriology.

[22]  Hans Wolf-Watz,et al.  Molecular characterization of type III secretion signals via analysis of synthetic N‐terminal amino acid sequences , 2002, Molecular microbiology.

[23]  M. Norman,et al.  Yersinia YopE is targeted for type III secretion by N‐terminal, not mRNA, signals , 2001, Molecular microbiology.

[24]  Frank Thieme,et al.  Two Novel Type III-Secreted Proteins of Xanthomonas campestris pv. vesicatoria Are Encoded within the hrp Pathogenicity Island , 2002, Journal of bacteriology.

[25]  Yejun Wang,et al.  T3_MM: A Markov Model Effectively Classifies Bacterial Type III Secretion Signals , 2013, PloS one.

[26]  U. Bonas,et al.  XopC and XopJ, Two Novel Type III Effector Proteinsfrom Xanthomonas campestris pv.vesicatoria , 2003, Journal of bacteriology.

[27]  Ram Samudrala,et al.  Accurate Prediction of Secreted Substrates and Identification of a Conserved Putative Secretion Signal for Type III Secretion Systems , 2009, PLoS pathogens.

[28]  Liam J. McGuffin,et al.  The PSIPRED protein structure prediction server , 2000, Bioinform..

[29]  Qingguo Wang,et al.  MUFOLD: A new solution for protein 3D structure prediction , 2010, Proteins.

[30]  J. Galán,et al.  Common themes in the design and function of bacterial effectors. , 2009, Cell host & microbe.

[31]  Thomas Rattei,et al.  Sequence-Based Prediction of Type III Secreted Proteins , 2009, PLoS pathogens.

[32]  Tomoko Kubori,et al.  Molecular and functional analysis of the type III secretion signal of the Salmonella enterica InvJ protein , 2002, Molecular microbiology.

[33]  Hans Wolf-Watz,et al.  Protein delivery into eukaryotic cells by type III secretion machines , 2006, Nature.

[34]  Daoguo Zhou,et al.  The First 45 Amino Acids of SopA Are Necessary for InvB Binding and SPI-1 Secretion , 2006, Journal of bacteriology.

[35]  J. Galán,et al.  Cloning and molecular characterization of genes whose products allow Salmonella typhimurium to penetrate tissue culture cells. , 1989, Proceedings of the National Academy of Sciences of the United States of America.

[36]  W. Hardt,et al.  A secreted Salmonella protein with homology to an avirulence determinant of plant pathogenic bacteria. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[37]  Yejun Wang,et al.  Salmonella: Both eliciting effective anti-tumor immunity , 2008 .

[38]  T. McDaniel,et al.  Enteropathogenic Escherichia coli contains a putative type III secretion system necessary for the export of proteins involved in attaching and effacing lesion formation. , 1995, Proceedings of the National Academy of Sciences of the United States of America.

[39]  T. Rattei,et al.  Targeting effectors: the molecular recognition of Type III secreted proteins. , 2010, Microbes and infection.

[40]  J. Galán,et al.  Temporal Regulation of Salmonella Virulence Effector Function by Proteasome-Dependent Protein Degradation , 2003, Cell.

[41]  J. Skolnick,et al.  Ab initio modeling of small proteins by iterative TASSER simulations , 2007, BMC Biology.

[42]  Qing Zhang,et al.  High-accuracy prediction of bacterial type III secreted effectors based on position-specific amino acid composition profiles , 2011, Bioinform..

[43]  Alexander J. Smola,et al.  Learning with kernels , 1998 .

[44]  Pierre Baldi,et al.  SCRATCH: a protein structure and structural feature prediction server , 2005, Nucleic Acids Res..

[45]  J. Burian,et al.  High efficiency gene replacement in Salmonella enteritidis: chimeric fimbrins containing a T-cell epitope from Leishmania major. , 1999, Vaccine.

[46]  Qing Zhang,et al.  T3DB: an integrated database for bacterial type III secretion system , 2012, BMC Bioinformatics.

[47]  R A Sayle,et al.  RASMOL: biomolecular graphics for all. , 1995, Trends in biochemical sciences.